Application of metagenomic next-generation sequencing in patients with infective endocarditis

被引:3
|
作者
Li, Shao-Lin [1 ]
Zhao, Xi [1 ]
Tao, Jun-Zhong [1 ]
Yue, Zhen-Zhen [1 ]
Zhao, Xiao-Yan [1 ]
机构
[1] Zhengzhou Univ, Cardiovasc Ctr, Dept Cardiol, Henan Key Lab Hereditary Cardiovasc Dis,Affiliated, Zhengzhou, Henan, Peoples R China
关键词
metagenomic next-generation sequencing; infective endocarditis; culture-negative; culture-positive; antibiotic regimen; CULTURE-NEGATIVE ENDOCARDITIS; CHALLENGES; DIAGNOSIS;
D O I
10.3389/fcimb.2023.1107170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ObjectivesMetagenomic next-generation sequencing (mNGS) technology is helpful for the early diagnosis of infective endocarditis, especially culture-negative infective endocarditis, which may guide clinical treatment. The purpose of this study was to compare the presence of culture-negative infective endocarditis pathogens versus culture-positive ones, and whether mNGS test results could influence treatment regimens for patients with routine culture-negative infective endocarditis. MethodsThe present study enrolled patients diagnosed with infective endocarditis and tested for mNGS in the First Affiliated Hospital of Zhengzhou University from February 2019 to February 2022 continuously. According to the culture results, patients were divided into culture-negative group (Group CN, n=18) and culture-positive group (Group CP, n=32). The baseline characteristics, clinical data, pathogens, 30 day mortality and treatment regimen of 50 patients with infective endocarditis were recorded and analyzed. ResultsExcept for higher levels of PCT in the Group CN [0.33 (0.16-2.74) ng/ml vs. 0.23 (0.12-0.49) ng/ml, P=0.042], there were no significant differences in the basic clinical data and laboratory examinations between the two groups (all P>0.05). The aortic valve and mitral valve were the most involved valves in patients with infective endocarditis (aortic valve involved: Group CN 10, Group CP 16; mitral valve involved: Group CN 8, Group CP 21; P>0.05) while 9 patients had multiple valves involved (Group CN 2, Group CP 7; P>0.05). The detection rate of non-streptococci infections in the Group CN was significantly higher than that in the Group CP (9/18 vs. 3/32, P=0.004). There was no significant difference in patients with heart failure hospitalization and all-cause death at 30 days after discharge (3 in Group CN vs. 4 in Group CP, P>0.05). It is worth noting that 10 patients with culture-negative infective endocarditis had their antibiotic regimen optimized after the blood mNGS. ConclusionsCulture-negative infective endocarditis should be tested for mNGS for early diagnosis and to guide clinical antibiotic regimen.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Utility of Metagenomic Next-Generation Sequencing in Infective Endocarditis: A Systematic Review
    Haddad, Sara F.
    DeSimone, Daniel C.
    Chesdachai, Supavit
    Gerberi, Danielle J.
    Baddour, Larry M.
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (12):
  • [2] Case Report: Mycobacterium kansasii causing infective endocarditis explored by metagenomic next-generation sequencing
    Yang, Liuqing
    Peng, Ling
    Yuan, Ke
    Cai, Kanru
    Feng, Cheng
    Yang, Gendong
    Wang, Shunyao
    Zhu, Xiuyun
    Zhang, Jieyun
    Wang, Fuxiang
    Lu, Hongzhou
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [3] Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients
    Liu, Yong
    Wu, Wencai
    Xiao, Yunping
    Zou, Hongyan
    Hao, Sijia
    Jiang, Yanfang
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [4] Metagenomic next-generation sequencing (mNGS)-assisted diagnosis of a case with infective endocarditis caused by Bartonella species
    Xu, Le
    Huang, XiaoYing
    Hou, Jianglong
    Ji, Peng
    [J]. ASIAN JOURNAL OF SURGERY, 2023, 46 (11) : 4966 - 4967
  • [5] The clinical value of valve metagenomic next-generation sequencing when applied to the etiological diagnosis of infective endocarditis
    Cai, Sishi
    Yang, Ye
    Pan, Jue
    Miao, Qing
    Jin, Wenting
    Ma, Yuyan
    Zhou, Chunmei
    Gao, Xiaodong
    Wang, Chunsheng
    Hu, Bijie
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (19)
  • [6] The clinical application of metagenomic next-generation sequencing in sepsis of immunocompromised patients
    Li, Xingxing
    Liang, Shunda
    Zhang, Dan
    He, Miao
    Zhang, Hong
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [7] Application of metagenomic next-generation sequencing in cutaneous tuberculosis
    Kong, Min
    Li, Wei
    Kong, Qingsheng
    Dong, Haixin
    Han, Aizhong
    Jiang, Liqing
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [8] A Case Report of Infective Endocarditis with Failure of the Empirical Treatment-Q Fever Endocarditis Diagnosed by Metagenomic Next-Generation Sequencing
    Lin, Guo-Shuai
    Zhao, Mao-Mao
    Li, Xiao-Qing
    Yu, Hong-Xia
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 2545 - 2550
  • [9] Coxiella burnetii and Bartonella Endocarditis Diagnosed by Metagenomic Next-Generation Sequencing
    Wang, Weiteng
    Chen, Oudi
    Liu, Weijiang
    Gan, Lixi
    Li, Xin
    Ma, Qingyan
    Hu, Xuejiao
    Jian, Xuhua
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [10] Application of Metagenomic Next-Generation Sequencing in the Etiological Diagnosis of Infective Endocarditis During the Perioperative Period of Cardiac Surgery: A Prospective Cohort Study
    Zeng, Xiaodong
    Wu, Jinlin
    Li, Xin
    Xiong, Weiping
    Tang, Lili
    Li, Xueming
    Zhuang, Jian
    Yu, Ruoying
    Chen, Jimei
    Jian, Xuhua
    Lei, Liming
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9